New Study Reveals Natural Supplement Supercharges Viagra's Effectiveness Without Added Side Effects
Presented at the Sexual Medicine Society of North America, the findings could help millions of men
Tens of millions of men worldwide use PDE-5 inhibitors such as Viagra® and Cialis® to treat erectile dysfunction. Millions of men cannot tolerate full doses due to side effects like headache, flushing, and reflux, limiting the medications' effectiveness.
The Results:
- 34% stronger erections when AFFIRM was combined with Viagra® (p=0.00004)
- 20% more frequent nighttime erections (p=0.034)
- No increase in side effects reported
"This study provides the first objective evidence that combining a nitric oxide–boosting supplement, like AFFIRM, with a PDE-5 inhibitor like Viagra® can improve erectile quality without adding side effects," said
Erectile dysfunction affects more than 30 million men in the
This study was industry-initiated, executed, and funded by BrandeisMD.
For more, please visit: https://www.affirmscience.com/collections/affirm-science-retail-products/products/copy-of-affirm-180-pills-1-bottle-shockwave-treatment
For interviews or questions regarding this breakthrough study, please contact:
BrandeisMD Inc.
925-255-7867
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-study-reveals-natural-supplement-supercharges-viagras-effectiveness-without-added-side-effects-302584859.html
SOURCE BrandeisMD Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Early Bird Tickets Now on Sale | ICOMIA & Sinoexpo Unveil 2027 ICOMIA World Marinas Conference (Shanghai) Preliminary Programme
- Hyperscale Data Bitcoin Treasury at Approximately 276 Bitcoin Worth Approximately $17.3 Million
- Black Kite Research Reveals That Ransomware's Primary Target Is the Mid-Market, Not Enterprises as Widely Assumed
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share